![]() |
市場調查報告書
商品編碼
1499981
病患定位系統市場評估:依產品、應用、最終使用者和地區劃分的機會和預測(2017-2031)Patient Positioning Systems Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球病患定位系統市場規模預計將從 2023 年的 13.6 億美元成長到 2031 年的 18.7 億美元,預測期內複合年增長率為 4.12%。
影響全球病患定位系統市場的因素有很多,包括研究投資的增加、技術的進步、癌症治療中使用的增加、手術台需求的增加等。
增加研究投資推動市場成長:
持續投資研究將有助於發現和開發推動市場發展的創新解決方案。在外科手術中,準確的患者定位對於確保患者安全至關重要。研究有助於識別潛在風險並制定措施來減少風險並確保患者獲得最佳結果。創新產品有助於增加進入診斷和手術目的部位和器官的機會。瞭解患者的需求和偏好有助於減輕患者的壓力和不適,並有助於開發更具支撐性和舒適性的定位解決方案。
不斷進步的技術進步推動市場成長:
全球病患定位系統市場正在部署許多技術,推動創新。機器人設備和技術被納入患者定位系統中,以提高準確性和生產力。透過自動化患者定位等流程,這些技術可以減少人為錯誤的可能性並提高患者的安全。使用人工智慧和機器學習分析患者數據並優化患者安置。透過識別可能的問題並相應地修改放置位置,這些設備可以幫助改善患者的治療效果。 VR/AR 技術也用於透過提供身臨其境的體驗來改善患者的定位,幫助患者瞭解治療並為治療做好準備。這樣可以增加患者的參與感,減少焦慮感。
癌症治療中使用的增加推動市場成長:
事實證明,患者定位系統對癌症患者非常有益,促使市場快速成長。在放射治療過程中,癌症患者通常處於仰臥或仰臥位。然而,對於某些癌症,例如胸部、骨盆和頭頸腫瘤,站直可以幫助管理治療,甚至可以改善患者的治療效果。有些患者可能會發現在直立治療時呼吸更容易,從而增加了腫瘤的輻射暴露並降低了附近健康組織的輻射劑量。
本報告調查了全球患者定位系統市場,提供了市場定義和概述、市場規模趨勢和預測、各個細分市場和地區的詳細分析、行業結構以及影響市場成長的因素。等等。
Global patient positioning systems market is projected to witness a CAGR of 4.12% during the forecast period 2024-2031, growing from USD 1.36 billion in 2023 to USD 1.87 billion in 2031. Various factors shape the global patient positioning systems market. These include increased investments in research, technological advancements, increasing use in cancer therapy, and rise in demand for surgical tables.
Numerous factors are responsible for the growth of the global patient positioning systems market including the rise of healthcare expenditure in many countries, especially in improving healthcare infrastructure. It is expected that the global patient positioning systems market will be highly driven by advanced technologies, such as robotic systems, that would increase the efficiency and accuracy of the patient positioning systems, leading to their increased adoption in the industry. The global patient positioning systems market will also be affected by the increasing frequency of chronic diseases that will drive the demand for technologically advanced centers that will solve the overcrowding in diagnostic centers in the coming decade.
The global patient positioning systems market will also be affected by the devices that offer stability, accessibility, and comfort, which are in high demand due to the growing geriatric population and the rising incidence of chronic illnesses like cancer, heart disease, and orthopedic disorders. Patient positioning system demand is anticipated to be driven by government investments in modernizing hospital operating rooms and healthcare infrastructure, as demonstrated by the Alberta government's commitment to modernizing hospital operating rooms. Increasing research funding is one important factor contributing to design and technological developments that improve positioning systems' accuracy and flexibility. The global patient positioning systems market is expanding because of the increasing usage of patient positioning systems in cancer treatment. Another important factor is the growing need for surgical tables, especially in the European market.
For example, the world leader in medical positioning innovations will now be known as CQ Medical, according to a 2023 announcement made by LUDWIG+, a woman-owned brand actualization and business acceleration firm. With a new name, new brand identity, and new campaign, LUDWIG+ is spearheading the new brand's comprehensive repositioning in the very competitive medical positioning innovation industry. Leading manufacturers of medical positioning devices, CIVCO Radiotherapy (RT) and QFix, which were the top two brands in the patient-centric radiotherapy industry, merged to establish CQ Medical. Care Quotient, or CQ for short, is the total of IQ and EQ as determined by the business culture.
Increased Investments in Research Drive Market Growth
Consistent investments in research will help in the discovery and development of innovative solutions that would drive the global patient positioning systems market. During surgical procedures, accurate patient placement is essential to guarantee patient safety. Research assists in identifying potential dangers and developing measures to mitigate them and ensure best possible outcomes for patients. Innovative products aid in increasing the accessibility to the site or the organ for diagnostics and surgical purposes. Research can result in the development of more supportive and pleasant positioning solutions, which will reduce patient stress and discomfort by understanding patients' needs and preferences.
For example, the prestigious Japanese hospital Gunma University Heavy Ion Medical Center announced in June 2024 that it will implement Leo Cancer Care's demonstration upright patient positioning system to lead new studies on the repeatability of upright positioning and innovative immobilization methods. With its gantry-less design that allows patients to be rotated upright, Leo Cancer Care aims to transform the sector by offering patients 360 degrees of freedom and maybe accessing malignancies that are now inaccessible. By supporting this groundbreaking research, the hospital hopes to validate an upright stance for carbon ion therapy in the future.
Increasing Technological Advancements to Fuel Market Growth
Numerous technologies are creating a stir in the global patient positioning systems market, propelling innovations. Robotic devices and technologies are included in patient positioning systems to improve accuracy and productivity. By automating processes like patient placement, these technologies can reduce the possibility of human error and increase patient safety. Patient data is analyzed, and patient placement is optimized using AI and ML. By identifying possible issues and modifying placement accordingly, these devices can assist in improving patient outcomes. By offering immersive experiences that assist patients in understanding and getting ready for treatments, VR/AR technologies are being used to improve patient positioning. This can boost patient participation and reduce anxiety.
For example, Middleton-based Leo Cancer Care Ltd. announced in May 2024 that it received regulatory approval for their ground-breaking upright patient positioning device, which allows patients to receive radiation therapy. Leo Cancer Care's upright technology has been granted 510k designation and permission by the FDA to be made available to healthcare professionals nationwide for immediate patient treatment.
Increasing Use in Cancer Therapy Propels Market Growth
Patient positioning systems prove to be highly beneficial for cancer patients, leading to exponential growth in the global patient positioning systems market. During radiation therapy, cancer patients usually lie supine or on their back. However, standing up straight can help with therapy administration and potentially even improve the patient prognosis for certain cancers, such as thoracic, pelvic, and head and neck tumors. Certain patients may find it easier to breathe during upright treatments, which may also increase tumor exposure and lower radiation doses to nearby healthy tissue. However, immobilizing the patient is essential for the safe execution of upright radiation therapy. The positioning system, sometimes referred to as "the chair," is made to arrange the patient in positions that are suitable for the type of cancer being treated. Patients are positioned on the chair with their knee rest and the back of their thigh supporting them during pelvic and prostate treatments.
For instance, BizLink Holding Inc., a leading provider of global interconnect solutions, stated with pride in January 2024 that they had successfully delivered their 100th ORION patient positioning system, a noteworthy milestone in the global advancement of precision cancer treatment. Held at BizLink Robotic Solutions France in Chartres, the jubilee celebration showcased the joint achievement of both organizations. The achievement represents a dedication to giving cancer patients the best care possible and eventually saving lives, going beyond simple sales success.
Rise in Demand for Surgical Tables to Boost Market Growth
There is a high demand for surgical tables in the global patient positioning systems market. Surgical tables are crucial for immobilizing patients during surgical procedures, as they help properly place a patient, guaranteeing the best possible access to the surgical site. In addition to minimizing movement, this placement lowers the chance of problems such as pressure injuries, skin deterioration, and nerve damage. Various immobilization devices, including leg holds, arm boards, and straps, are used on surgical tables to hold the patient in place. These tools aid in keeping the patient still and secure by minimizing movement while the surgery is being performed.
For instance, the Maquet Corin is an operating room (OR) table that is safe, smart, connected, and easy to use. It was presented in October 2023 by Getinge AB, a global leader in medical technology, to streamline daily operations in today's hectic surgical departments. Maquet Corin advances in areas where surgical teams greatly benefit. Its adaptability and simplicity of use promote collaboration and communication, which saves time. Smart sensor-based safety features are also included to help safeguard OR personnel and equipment.
European Market to Grow in the Forecast Period
Chronic diseases like cancer, heart disease, and orthopedic disorders are very common in Europe and are responsible for the steady growth of the global patient positioning systems market. There is an increasing need for patient positioning devices due to the aging population and rising incidence of certain diseases, which ensures comfort, stability, and accessibility during a variety of medical operations. It guarantees precise and comfortable positioning throughout various diagnostic procedures, this is fueling the demand for patient positioning devices. Due to programs like the National Awareness and Early Diagnosis Initiative (NAEDI) in the United Kingdom, Europe is seeing a rise in the number of diagnostic procedures, such as imaging tests.
For example, Leo Cancer Care Ltd. announced in April 2024 that one of the most advanced oncology facilities in the world will get proton and carbon ion radiation therapy using its innovative upright radiotherapy system. An innovative agreement has been reached with Pavia, Italy's National Centre for Oncological Hadrontherapy (CNAO). In front of an existing fixed radiation beam, Marie will combine an upright patient positioning system with a vertical CT scanner. Patients will be smoothly and slowly rotated to changing beam angles while receiving treatment.
Future Market Scenario (2024-2031F)
It is anticipated that the increase in demand for smart patient positioning systems is going to drive the demand for the global patient positioning systems market.
Developing nations like Brazil, China, and India are expected to present substantial expansion prospects for the global patient positioning systems market.
Improvements in design and materials are driving the global patient positioning systems market to create patient positioning solutions that are more robust and comfortable.
Systems for patient positioning are becoming increasingly crucial for streamlining operations in medical facilities, driving the growth of the global patient positioning systems market.
Key Players Landscape and Outlook
Many leading players in the global patient positioning systems market are engaging in collaborations and mergers to fully utilize the opportunities that the industry is offering. These strategic alliances are crucial for businesses as they collaborate to develop a whole range of treatments and technologies that could help both physicians and patients. The companies aim to create innovative products and services by bringing together the expertise of different entities making use of the latest technologies.
For example, an exclusive strategic partnership with Leo Cancer Care Ltd. was announced in October 2023 by Aviko Radiopharmaceuticals, a biotechnology company founded by Deerfield Management that is focused on developing medicines to unlock the potential of boron neutron capture therapy (BNCT), and Neutron Therapeutics, a leading developer of accelerator-based neutron systems for targeted radiation therapy of solid tumors. The collaboration aims to increase the potential applications of BNCT as a cancer treatment. To replace outdated nuclear reactors for BNCT, Neutron's nuBeam therapy platform-a small, in-hospital neutron source-will use Leo Cancer Care's upright patient positioning system.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.